Suchergebnisse - "Partin, Alan W."

PubPharm (145)

1

ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2023

von Salles, D. | Mendes, A. | Han, M. | +4

2

Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy

enthalten in: The Journal of urology | 2022

von Trock, B. | Jing, Y. | Mabey, B. | +15

3

Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer

enthalten in: Medical oncology (Northwood, London, England) | 2022

von Reyes, D. | Trock, B. | Tran, P. | +11

4

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

enthalten in: Clinical genitourinary cancer | 2019

von Markowski, M. | Chen, Y. | Feng, Z. | +10

5

Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer

enthalten in: BJU international | 2019

von Gupta, N. | Bivalacqua, T. | Han, M. | +4

6

Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy

enthalten in: The Journal of urology | 2018

von Patel, H. | Gupta, M. | Tosoian, J. | +3

CommentIn: J Urol. 2018 Nov;200(5):1074. - PMID 30055133

7

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer

enthalten in: BJU international | 2018

von Druskin, S. | Tosoian, J. | Young, A. | +9

8

Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer : Results of a Prospective, Phase II, Single Center Study

enthalten in: The Journal of urology | 2018

von Gorin, M. | Rowe, S. | Patel, H. | +13

9

Prostate Health Index density improves detection of clinically significant prostate cancer

enthalten in: BJU international | 2017

von Tosoian, J. | Druskin, S. | Andreas, D. | +10

CommentIn: BJU Int. 2017 Dec;120(6):745-746. - PMID 29168335

10

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

enthalten in: BJU international | 2017

von Loeb, S. | Shin, S. | Broyles, D. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]